請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/50983完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 江伯倫(Bor-Luen Chiang) | |
| dc.contributor.author | Szu-Ying Chen | en |
| dc.contributor.author | 陳思縈 | zh_TW |
| dc.date.accessioned | 2021-06-15T13:10:37Z | - |
| dc.date.available | 2018-08-26 | |
| dc.date.copyright | 2016-08-26 | |
| dc.date.issued | 2016 | |
| dc.date.submitted | 2016-06-27 | |
| dc.identifier.citation | Afzali, B., P. J. Mitchell, F. C. Edozie, G. A. Povoleri, S. E. Dowson, L. Demandt, G. Walter, J. B. Canavan, C. Scotta, B. Menon, P. S. Chana, W. Khamri, S. Y. Kordasti, S. Heck, B. Grimbacher, T. Tree, A. P. Cope, L. S. Taams, R. I. Lechler, S. John and G. Lombardi (2013). 'CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner.' Eur J Immunol 43(8): 2043-2054.
Aricha, R., D. Reuveni, S. Fuchs and M. C. Souroujon (2016). 'Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.' J Autoimmun 67: 57-64. Benson, M. J., K. Pino-Lagos, M. Rosemblatt and R. J. Noelle (2007). 'All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.' J Exp Med 204(8): 1765-1774. Bijlsma, J. W., K. G. Saag, F. Buttgereit and J. A. da Silva (2005). 'Developments in glucocorticoid therapy.' Rheum Dis Clin North Am 31(1): 1-17, vii. Boissier, M. C. (2011). 'Cell and cytokine imbalances in rheumatoid synovitis.' Joint Bone Spine 78(3): 230-234. Brand, D. D., A. H. Kang and E. F. Rosloniec (2003). 'Immunopathogenesis of collagen arthritis.' Springer Semin Immunopathol 25(1): 3-18. Brand, D. D., K. A. Latham and E. F. Rosloniec (2007). 'Collagen-induced arthritis.' Nat Protoc 2(5): 1269-1275. Buckner, J. H. and S. F. Ziegler (2004). 'Regulating the immune system: the induction of regulatory T cells in the periphery.' Arthritis Res Ther 6(5): 215-222. Buelens, C., F. Willems, A. Delvaux, G. Pierard, J. P. Delville, T. Velu and M. Goldman (1995). 'Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells.' Eur J Immunol 25(9): 2668-2672. Buttgereit, F., K. G. Saag, M. Cutolo, J. A. da Silva and J. W. Bijlsma (2005). 'The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.' Scand J Rheumatol 34(1): 14-21. Buttgereit, F., R. H. Straub, M. Wehling and G. R. Burmester (2004). 'Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.' Arthritis Rheum 50(11): 3408-3417. Byng-Maddick, R. and M. R. Ehrenstein (2015). 'The impact of biological therapy on regulatory T cells in rheumatoid arthritis.' Rheumatology (Oxford) 54(5): 768-775. Canete, J. D., S. E. Martinez, J. Farres, R. Sanmarti, M. Blay, A. Gomez, G. Salvador and J. Munoz-Gomez (2000). 'Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies.' Ann Rheum Dis 59(4): 263-268. Charbonnier, L. M., W. G. Han, J. Quentin, T. W. Huizinga, J. Zwerina, R. E. Toes, C. Jorgensen and P. Louis-Plence (2010). 'Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis.' J Autoimmun 34(4): 390-399. Chen, L. C., J. C. Delgado, P. E. Jensen and X. Chen (2009). 'Direct expansion of human allospecific Foxp3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application.' J Immunol 183(6): 4094-4102. Chen, X. and P. E. Jensen (2007). 'Cutting edge: primary B lymphocytes preferentially expand allogeneic Foxp3+ CD4 T cells.' J Immunol 179(4): 2046-2050. Chien, C. H., H. H. Yu and B. L. Chiang (2015). 'Single allergen-induced oral tolerance inhibits airway inflammation in conjugated allergen immunized mice.' J Allergy Clin Immunol 136(4): 1110-1113 e1114. Chiu, C. J., T. Y. Ling and B. L. Chiang (2015). 'Lung-derived SSEA-1(+) stem/progenitor cells inhibit allergic airway inflammation in mice.' Allergy 70(4): 374-383. Chu, K. H. and B. L. Chiang (2012). 'Regulatory T cells induced by mucosal B cells alleviate allergic airway hypersensitivity.' Am J Respir Cell Mol Biol 46(5): 651-659. Chu, K. H. and B. L. Chiang (2015). 'Characterization and functional studies of forkhead box protein 3(-) lymphocyte activation gene 3(+) CD4(+) regulatory T cells induced by mucosal B cells.' Clin Exp Immunol 180(2): 316-328. Cobbold, S. P., E. Adams, C. A. Farquhar, K. F. Nolan, D. Howie, K. O. Lui, P. J. Fairchild, A. L. Mellor, D. Ron and H. Waldmann (2009). 'Infectious tolerance via the consumption of essential amino acids and mTOR signaling.' Proc Natl Acad Sci U S A 106(29): 12055-12060. Collison, L. W., V. Chaturvedi, A. L. Henderson, P. R. Giacomin, C. Guy, J. Bankoti, D. Finkelstein, K. Forbes, C. J. Workman, S. A. Brown, J. E. Rehg, M. L. Jones, H. T. Ni, D. Artis, M. J. Turk and D. A. Vignali (2010). 'IL-35-mediated induction of a potent regulatory T cell population.' Nat Immunol 11(12): 1093-1101. Colmegna, I., B. R. Ohata and H. A. Menard (2012). 'Current understanding of rheumatoid arthritis therapy.' Clin Pharmacol Ther 91(4): 607-620. Djouad, F., V. Fritz, F. Apparailly, P. Louis-Plence, C. Bony, J. Sany, C. Jorgensen and D. Noel (2005). 'Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.' Arthritis Rheum 52(5): 1595-1603. Dons, E. M., G. Raimondi, D. K. Cooper and A. W. Thomson (2012). 'Induced regulatory T cells: mechanisms of conversion and suppressive potential.' Hum Immunol 73(4): 328-334. Dorner, T. and G. R. Burmester (2003). 'The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets.' Curr Opin Rheumatol 15(3): 246-252. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg and C. Mauri (2004). 'Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy.' J Exp Med 200(3): 277-285. Fantini, M. C., C. Becker, G. Monteleone, F. Pallone, P. R. Galle and M. F. Neurath (2004). 'Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.' J Immunol 172(9): 5149-5153. Firestein, G. S. (2003). 'Evolving concepts of rheumatoid arthritis.' Nature 423(6937): 356-361. Franklin, E. C., H. R. Holman, H. J. Muller-Eberhard and H. G. Kunkel (1957). 'An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis.' J Exp Med 105(5): 425-438. Gilmore, W., L. P. Weiner and J. Correale (1997). 'Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects.' J Immunol 158(1): 446-451. Gregersen, P. K., J. Silver and R. J. Winchester (1987). 'The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.' Arthritis Rheum 30(11): 1205-1213. Herrath, J., M. Muller, P. Amoudruz, P. Janson, J. Michaelsson, P. T. Larsson, C. Trollmo, S. Raghavan and V. Malmstrom (2011). 'The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function.' Eur J Immunol 41(8): 2279-2290. Himmel, M. E., K. G. MacDonald, R. V. Garcia, T. S. Steiner and M. K. Levings (2013). 'Helios+ and Helios- cells coexist within the natural Foxp3+ T regulatory cell subset in humans.' J Immunol 190(5): 2001-2008. Hippen, K. L., J. L. Riley, C. H. June and B. R. Blazar (2011). 'Clinical perspectives for regulatory T cells in transplantation tolerance.' Semin Immunol 23(6): 462-468. Hochberg, M. C. (2009). Rheumatoid arthritis. Philadelphia, PA, Mosby/Elsevier. Hoffmann, P., R. Eder, T. J. Boeld, K. Doser, B. Piseshka, R. Andreesen and M. Edinger (2006). 'Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.' Blood 108(13): 4260-4267. Hoffmann, P., J. Ermann, M. Edinger, C. G. Fathman and S. Strober (2002). 'Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.' J Exp Med 196(3): 389-399. Hsu, L. H., K. P. Li, K. H. Chu and B. L. Chiang (2015). 'A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.' Cell Mol Immunol 12(3): 354-365. Hsu, W. T., C. H. Lin, B. L. Chiang, H. Y. Jui, K. K. Wu and C. M. Lee (2013). 'Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-gamma+CD4+ regulatory T cells to control transplant arteriosclerosis.' J Immunol 190(5): 2372-2380. Huang, Z., B. Yang, Y. Shi, B. Cai, Y. Li, W. Feng, Y. Fu, L. Luo and L. Wang (2012). 'Anti-TNF-alpha therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis.' Cell Immunol 279(1): 25-29. Kambayashi, T. and T. M. Laufer (2014). 'Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?' Nat Rev Immunol 14(11): 719-730. Karagiannidis, C., M. Akdis, P. Holopainen, N. J. Woolley, G. Hense, B. Ruckert, P. Y. Mantel, G. Menz, C. A. Akdis, K. Blaser and C. B. Schmidt-Weber (2004). 'Glucocorticoids upregulate Foxp3 expression and regulatory T cells in asthma.' J Allergy Clin Immunol 114(6): 1425-1433. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis and G. Kollias (1991). 'Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.' EMBO J 10(13): 4025-4031. Kelchtermans, H., L. Geboes, T. Mitera, D. Huskens, G. Leclercq and P. Matthys (2009). 'Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.' Ann Rheum Dis 68(5): 744-750. Kong, N., Q. Lan, M. Chen, J. Wang, W. Shi, D. A. Horwitz, V. Quesniaux, B. Ryffel, Z. Liu, D. Brand, H. Zou and S. G. Zheng (2012). 'Antigen-specific transforming growth factor beta-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance.' Arthritis Rheum 64(8): 2548-2558. Kong, N., Q. Lan, M. Chen, T. Zheng, W. Su, J. Wang, Z. Yang, R. Park, G. Dagliyan, P. S. Conti, D. Brand, Z. Liu, H. Zou, W. Stohl and S. G. Zheng (2012). 'Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells.' Ann Rheum Dis 71(9): 1567-1572. Koreth, J., K. Matsuoka, H. T. Kim, S. M. McDonough, B. Bindra, E. P. Alyea, 3rd, P. Armand, C. Cutler, V. T. Ho, N. S. Treister, D. C. Bienfang, S. Prasad, D. Tzachanis, R. M. Joyce, D. E. Avigan, J. H. Antin, J. Ritz and R. J. Soiffer (2011). 'Interleukin-2 and regulatory T cells in graft-versus-host disease.' N Engl J Med 365(22): 2055-2066. Kremers, H. M., P. J. Nicola, C. S. Crowson, K. V. Ballman and S. E. Gabriel (2004). 'Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.' Arthritis Rheum 50(11): 3450-3457. Liang, B., C. Workman, J. Lee, C. Chew, B. M. Dale, L. Colonna, M. Flores, N. Li, E. Schweighoffer, S. Greenberg, V. Tybulewicz, D. Vignali and R. Clynes (2008). 'Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.' J Immunol 180(9): 5916-5926. Lu, F. T., W. Yang, Y. H. Wang, H. D. Ma, W. Tang, J. B. Yang, L. Li, A. A. Ansari and Z. X. Lian (2015). 'Thymic B cells promote thymus-derived regulatory T cell development and proliferation.' J Autoimmun 61: 62-72. MacKay, K., A. Milicic, D. Lee, M. Tikly, S. Laval, J. Shatford and P. Wordsworth (2003). 'Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations.' Rheumatology (Oxford) 42(1): 149-153. Masteller, E. L., M. R. Warner, Q. Tang, K. V. Tarbell, H. McDevitt and J. A. Bluestone (2005). 'Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice.' J Immunol 175(5): 3053-3059. McGovern, J. L., D. X. Nguyen, C. A. Notley, C. Mauri, D. A. Isenberg and M. R. Ehrenstein (2012). 'Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.' Arthritis Rheum 64(10): 3129-3138. McInnes, I. B. and G. Schett (2007). 'Cytokines in the pathogenesis of rheumatoid arthritis.' Nat Rev Immunol 7(6): 429-442. McInnes, I. B. and G. Schett (2011). 'The pathogenesis of rheumatoid arthritis.' N Engl J Med 365(23): 2205-2219. Miyara, M., Y. Ito and S. Sakaguchi (2014). 'TREG-cell therapies for autoimmune rheumatic diseases.' Nat Rev Rheumatol 10(9): 543-551. Miyara, M., Y. Yoshioka, A. Kitoh, T. Shima, K. Wing, A. Niwa, C. Parizot, C. Taflin, T. Heike, D. Valeyre, A. Mathian, T. Nakahata, T. Yamaguchi, T. Nomura, M. Ono, Z. Amoura, G. Gorochov and S. Sakaguchi (2009). 'Functional delineation and differentiation dynamics of human CD4+ T cells expressing the Foxp3 transcription factor.' Immunity 30(6): 899-911. Morgan, M. E., R. Flierman, L. M. van Duivenvoorde, H. J. Witteveen, W. van Ewijk, J. M. van Laar, R. R. de Vries and R. E. Toes (2005). 'Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells.' Arthritis Rheum 52(7): 2212-2221. Morris, S. C., A. Lees and F. D. Finkelman (1994). 'In vivo activation of naive T cells by antigen-presenting B cells.' J Immunol 152(8): 3777-3785. Muller-Ladner, U., J. Kriegsmann, B. N. Franklin, S. Matsumoto, T. Geiler, R. E. Gay and S. Gay (1996). 'Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.' Am J Pathol 149(5): 1607-1615. Nelson, J. L., K. A. Hughes, A. G. Smith, B. B. Nisperos, A. M. Branchaud and J. A. Hansen (1993). 'Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis.' N Engl J Med 329(7): 466-471. Nie, H., Y. Zheng, R. Li, T. B. Guo, D. He, L. Fang, X. Liu, L. Xiao, X. Chen, B. Wan, Y. E. Chin and J. Z. Zhang (2013). 'Phosphorylation of Foxp3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis.' Nat Med 19(3): 322-328. Nielen, M. M., D. van Schaardenburg, H. W. Reesink, R. J. van de Stadt, I. E. van der Horst-Bruinsma, M. H. de Koning, M. R. Habibuw, J. P. Vandenbroucke and B. A. Dijkmans (2004). 'Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.' Arthritis Rheum 50(2): 380-386. Nishizuka, Y. and T. Sakakura (1969). 'Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice.' Science 166(3906): 753-755. O'Garra, A. and P. Vieira (2004). 'Regulatory T cells and mechanisms of immune system control.' Nat Med 10(8): 801-805. Okamura, T., K. Fujio, M. Shibuya, S. Sumitomo, H. Shoda, S. Sakaguchi and K. Yamamoto (2009). 'CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2.' Proc Natl Acad Sci U S A 106(33): 13974-13979. Okamura, T., K. Fujio, S. Sumitomo and K. Yamamoto (2012). 'Roles of LAG3 and EGR2 in regulatory T cells.' Ann Rheum Dis 71 Suppl 2: i96-100. Reichardt, P., B. Dornbach, S. Rong, S. Beissert, F. Gueler, K. Loser and M. Gunzer (2007). 'Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse.' Blood 110(5): 1519-1529. Safinia, N., J. Leech, M. Hernandez-Fuentes, R. Lechler and G. Lombardi (2013). 'Promoting transplantation tolerance; adoptive regulatory T cell therapy.' Clin Exp Immunol 172(2): 158-168. Sakaguchi, S., M. Miyara, C. M. Costantino and D. A. Hafler (2010). 'Foxp3+ regulatory T cells in the human immune system.' Nat Rev Immunol 10(7): 490-500. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh and M. Toda (1995). 'Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.' J Immunol 155(3): 1151-1164. Sakaguchi, S., T. Takahashi and Y. Nishizuka (1982). 'Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.' J Exp Med 156(6): 1565-1576. Sakaguchi, S., T. Yamaguchi, T. Nomura and M. Ono (2008). 'Regulatory T cells and immune tolerance.' Cell 133(5): 775-787. Schellekens, G. A., B. A. de Jong, F. H. van den Hoogen, L. B. van de Putte and W. J. van Venrooij (1998). 'Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.' J Clin Invest 101(1): 273-281. Schinnerling, K., P. Garcia-Gonzalez and J. C. Aguillon (2015). 'Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity.' Front Immunol 6: 528. Schooten, E., P. Klous, P. J. van den Elsen and T. M. Holling (2005). 'Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region.' Immunogenetics 57(10): 795-799. Schulze-Koops, H., P. E. Lipsky, A. F. Kavanaugh and L. S. Davis (1995). 'Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit.' J Immunol 155(10): 5029-5037. Scott, D. L. (2012). 'Biologics-based therapy for the treatment of rheumatoid arthritis.' Clin Pharmacol Ther 91(1): 30-43. Sekine, C., T. Nanki and H. Yagita (2014). 'Macrophage-derived delta-like protein 1 enhances interleukin-6 and matrix metalloproteinase 3 production by fibroblast-like synoviocytes in mice with collagen-induced arthritis.' Arthritis Rheumatol 66(10): 2751-2761. Shackelford, C., G. Long, J. Wolf, C. Okerberg and R. Herbert (2002). 'Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies.' Toxicol Pathol 30(1): 93-96. Shah, S. and L. Qiao (2008). 'Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF-beta3.' Eur J Immunol 38(9): 2488-2498. Sun, J. B., C. F. Flach, C. Czerkinsky and J. Holmgren (2008). 'B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.' J Immunol 181(12): 8278-8287. Symmons, D. P., C. R. Bankhead, B. J. Harrison, P. Brennan, E. M. Barrett, D. G. Scott and A. J. Silman (1997). 'Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England.' Arthritis Rheum 40(11): 1955-1961. Takahashi, T., Y. Kuniyasu, M. Toda, N. Sakaguchi, M. Itoh, M. Iwata, J. Shimizu and S. Sakaguchi (1998). 'Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.' Int Immunol 10(12): 1969-1980. Thornton, A. M., P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray, Y. Belkaid and E. M. Shevach (2010). 'Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.' J Immunol 184(7): 3433-3441. Thornton, A. M. and E. M. Shevach (2000). 'Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.' J Immunol 164(1): 183-190. Vermeire, K., H. Heremans, M. Vandeputte, S. Huang, A. Billiau and P. Matthys (1997). 'Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice.' J Immunol 158(11): 5507-5513. Vignali, D. A., L. W. Collison and C. J. Workman (2008). 'How regulatory T cells work.' Nat Rev Immunol 8(7): 523-532. Wehrens, E. J., B. J. Prakken and F. van Wijk (2013). 'T cells out of control--impaired immune regulation in the inflamed joint.' Nat Rev Rheumatol 9(1): 34-42. Williams, R. O., M. Feldmann and R. N. Maini (1992). 'Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.' Proc Natl Acad Sci U S A 89(20): 9784-9788. Woodrick, R. S. and E. M. Ruderman (2011). 'Safety of biologic therapy in rheumatoid arthritis.' Nat Rev Rheumatol 7(11): 639-652. Yadav, M., C. Louvet, D. Davini, J. M. Gardner, M. Martinez-Llordella, S. Bailey-Bucktrout, B. A. Anthony, F. M. Sverdrup, R. Head, D. J. Kuster, P. Ruminski, D. Weiss, D. Von Schack and J. A. Bluestone (2012). 'Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.' J Exp Med 209(10): 1713-1722, S1711-1719. Yudoh, K., H. Matsuno, F. Nakazawa, T. Yonezawa and T. Kimura (2000). 'Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.' Arthritis Rheum 43(3): 617-627. Zaiss, M. M., R. Axmann, J. Zwerina, K. Polzer, E. Guckel, A. Skapenko, H. Schulze-Koops, N. Horwood, A. Cope and G. Schett (2007). 'Treg cells suppress osteoclast formation: a new link between the immune system and bone.' Arthritis Rheum 56(12): 4104-4112. Zhou, X., N. Kong, J. Wang, H. Fan, H. Zou, D. Horwitz, D. Brand, Z. Liu and S. G. Zheng (2010). 'Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu.' J Immunol 185(5): 2675-2679. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/50983 | - |
| dc.description.abstract | 類風溼性關節炎是一主要針對四肢關節的自體免疫疾病，主要在病患關節的滑膜軟骨處有反覆性的發炎，最後導致關節不可逆之腫脹變形，然而目前尚未有完全根治的療法。已知此疾病在免疫致病機轉中，關節周圍浸潤的免疫細胞偏向發炎狀態，這些發炎性物質除了造成關節腫脹，也導致更多免疫細胞浸潤。
在先前的研究已發現，移植誘導型調節性T細胞 (induced regulatory T cells, iTreg) 於膠原蛋白誘導的關節炎(collagen-induced arthritis)小鼠內可改善疾病，因此本研究希望能藉體外培養出由B細胞誘導之調節性T細胞 (Treg-of-B)，改善小鼠的類風濕性關節炎。 本研究的實驗結果發現，B細胞誘導之調節性T細胞，表現和調節性T細胞相似的表面蛋白，例如CD25和LAG3，但不包含Foxp3。在T細胞增生實驗中也證實可藉LAG3分子及分泌抗發炎細胞素IL-10抑制CD4+CD25-T細胞的增生。進一步將這群B細胞誘導之調節性T細胞利用靜脈注射到類風溼性關節炎的小鼠模式中，發現四肢關節在臨床發炎分數有顯著降低；小鼠犧牲後，自脾臟及淋巴結取出的細胞也分泌較多IL-10；而關節組織之發炎性基因IL-6則降低；在小鼠的腳掌組織切片也觀察到移植Treg-of-B細胞的小鼠組別，其細胞浸潤和骨質溶解的程度也較為減緩。 綜合上述，可證實脾臟B細胞誘導調節性T細胞具減輕膠原蛋白誘發之小鼠關節炎的能力，此研究結果也提供未來使用不同誘導型調節性T細胞治療類風溼性關節炎或其他自體免疫疾病的治療潛力。 | zh_TW |
| dc.description.abstract | Rheumatoid arthritis (RA) is an autoimmune disease in which dysregulated immune cells primarily target synovial joints. Despite recent advances in the treatment of RA, including the introduction of biologic therapies and employment of combination disease-modifying antirheumatic drug strategies, remission rates remain suboptimal. Previous studies have demonstrated that the adoptive transfer of induced regulatory T cells (iTreg cells) was effective in treating a murine model of collagen-induced arthritis (CIA). The objective of this study was to develop optimal potential iTreg-based therapy for CIA by adoptively transferring LAG3+ Treg-of-B cells.
Our results showed that B-cell-induced Treg-of-B cells expressed LAG3 but not Foxp3 (designated LAG3+ Treg-of-B), and secreted IL-4, IL-10, and TGF-β. Furthermore, LAG3+ Treg-of-B cells suppressed the proliferation of CD4+CD25- responder T cells through both LAG3 and IL-10 production. In the murine CIA model, adoptive transfer of LAG3+ Treg-of-B cells alleviated the joint severity as well as local and systemic inflammation. Treatment with LAG3+ Treg-of-B cells also promoted IL-10 production in lymphocytes isolated from the spleen and draining lymph nodes. Moreover, mice receiving LAG3+ Treg-of-B cell treatment showed significantly less pronounced osteolysis in the hind footpads, which correlated with the downregulation of tartrate-resistant acid phosphatase expression. In conclusion, we identified a novel subset of Treg cells for CIA treatment. This insight may facilitate exploring novel regulatory T-cell-based therapies for human autoimmune diseases. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T13:10:37Z (GMT). No. of bitstreams: 1 ntu-105-D99421004-1.pdf: 6335715 bytes, checksum: ee5904e82d07992c38553ad00ab65fbd (MD5) Previous issue date: 2016 | en |
| dc.description.tableofcontents | 口試委員審定書 ................................................................................................................i
中文摘要 ........................................................................................................................... ii Abstract ............................................................................................................................. iii Abbreviations ................................................................................................................... iv Content pages .................................................................................................................... v Content of figures ............................................................................................................ vii Content of tables ............................................................................................................... ix Chapter 1. Introduction ..................................................................................................... 1 Section 1. Regulatory T cells ........................................................................................ 1 Section 2. Rheumatoid arthritis (RA) ........................................................................... 6 Section 3. Treg-based therapies of rheumatic diseases............................................... 13 Section 4. Aims of the study ....................................................................................... 15 Chapter 2. Materials and Methods .................................................................................. 17 Section 1. Animals for in vitro and in vivo model ...................................................... 17 Section 2. Materials and Methods for in vitro experiments ....................................... 18 Section 3. Materials and methods for in vivo animal study ....................................... 22 Section 4. Statistical analysis ..................................................................................... 24 Chapter 3. Results ........................................................................................................... 25 Section 1. Phenotypes, characteristics, and functions of LAG3+ Treg-of-B cells ...... 25 Section 2. Immunomodulation of LAG3+ Treg-of-B cells in murine CIA model ...... 31 Chapter 4. Discussion ..................................................................................................... 38 Section 1. Characteristics, functions, and suppressive mechanisms of Treg-of-B cells .................................................................................................................................... 38 Section 2. The immunomodulatory effect of LAG3+ Treg-of-B cells in murine CIA model. ......................................................................................................................... 40 Section 3. Conclusion ................................................................................................. 43 Chapter 5. Perspectives................................................................................................... 45 Section 1. Perspectives of Treg-cell therapies in rheumatic diseases ......................... 45 Section 2. The optimal function of Treg-of-B cells in future applications ................. 45 Chapter 6. References ..................................................................................................... 47 Chapter 7. Figures .......................................................................................................... 59 Chapter 8. Tables ............................................................................................................ 88 | |
| dc.language.iso | en | |
| dc.subject | 淋巴?胞活化基因3 | zh_TW |
| dc.subject | B細胞誘導調節性T細胞 | zh_TW |
| dc.subject | 淋巴?胞活化基因3 | zh_TW |
| dc.subject | 類風溼性關節炎 | zh_TW |
| dc.subject | B細胞誘導調節性T細胞 | zh_TW |
| dc.subject | 類風溼性關節炎 | zh_TW |
| dc.subject | Lymphocyte-activation gene 3 | en |
| dc.subject | Lymphocyte-activation gene 3 | en |
| dc.subject | Collagen-induced arthritis | en |
| dc.subject | Regulatory T cells | en |
| dc.subject | Rheumatoid arthritis | en |
| dc.subject | Collagen-induced arthritis | en |
| dc.subject | Regulatory T cells | en |
| dc.subject | Rheumatoid arthritis | en |
| dc.title | B細胞誘導調節性T細胞對關節發炎的免疫調控研究 | zh_TW |
| dc.title | Study on the Immunomodulatory Potential of Regulatory T cells Induced by B Cells in Joint Inflammation | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 104-2 | |
| dc.description.degree | 博士 | |
| dc.contributor.oralexamcommittee | 蔡長祐(Chang-Youh Tsai),繆希椿(Shi-Chuen Miaw),李岳倫(Yueh-Lun Lee),楊宏志(Hung-Chih Yang) | |
| dc.subject.keyword | 類風溼性關節炎,B細胞誘導調節性T細胞,淋巴?胞活化基因3, | zh_TW |
| dc.subject.keyword | Lymphocyte-activation gene 3,Collagen-induced arthritis,Regulatory T cells,Rheumatoid arthritis, | en |
| dc.relation.page | 89 | |
| dc.identifier.doi | 10.6342/NTU201600532 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2016-06-28 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
| 顯示於系所單位： | 臨床醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-105-1.pdf 未授權公開取用 | 6.19 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。